Clinical Trial

Transaxillary TAVR With Solely Echocardiography Guidance

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-16; most recent amendment 2026-02-26.
Status change: Active, Not Recruiting → Recruiting 2026-02-02
Trial Details
NCT Number NCT07035847
Lead Sponsor Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Aortic Stenosis
Enrollment 20 participants
Start Date 2024-10-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-27